Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial of RP-A501 in Danon Disease

https://adler.staging1090.pendari.com/wp-content/uploads/2022/01/rocket-pharmaceuticals-logo.jpeg 589 589 Adler Lab Adler Lab https://adler.staging1090.pendari.com/wp-content/uploads/2022/01/rocket-pharmaceuticals-logo.jpeg November 15, 2021 February 2, 2022